Communication
ChemComm
2 (a) X.-F. Wu, H. Neumann and M. Beller, Chem. Soc. Rev., 2011,
40, 4986; (b) X.-F. Wu, H. Neumann and M. Beller, Chem. Rev., 2013,
113, 1.
3 For selected reviews, see: (a) T. Morimoto and K. Kakiuchi, Angew.
Chem., Int. Ed., 2004, 43, 5580; (b) L. Wu, Q. Liu, R. Jackstell and
M. Beller, Angew. Chem., Int. Ed., 2014, 53, 6310; (c) H. Konishi and
K. Manabe, Synlett, 2014, 1971.
4 J. S. Morgan, J. Chem. Soc., Trans., 1916, 109, 274.
5 S. Cacchi, G. Fabrizi and A. Goggiamani, Org. Lett., 2003, 5, 4269.
6 Use of a strong base: (a) J.-F. Carpentier, Y. Castanet, J. Brocard,
A. Mortreux and F. Petit, Tetrahedron Lett., 1991, 32, 4705; (b) M. S.
Yalfani, G. Lolli, A. Wolf, L. Mleczko, T. E. Mu¨ller and W. Leitner, Green
Chem., 2013, 15, 1146. Use of several transition metals: (c) G. Jenner,
E. M. Nahmed and H. Leismann, J. Organomet. Chem., 1990, 387, 315.
7 Y. Wan, M. Alterman, M. Larhed and A. Hallberg, J. Org. Chem.,
2002, 67, 6232.
8 L. R. Odell, F. Russo and M. Larhed, Synlett, 2012, 685.
9 (a) T. Okano, T. Kobayashi, H. Konishi and J. Kiji, Tetrahedron Lett.,
1982, 23, 4967; (b) C. M. Beck, S. E. Rathmill, Y. J. Park, J. Chen,
R. H. Crabtree, L. M. Liable-Sands and A. L. Rheingold, Organo-
metallics, 1999, 18, 5311; (c) K. Fuji, T. Morimoto, K. Tsutsumi and
K. Kakiuchi, Angew. Chem., Int. Ed., 2003, 42, 2409.
10 P. Hermange, A. T. Lindhardt, R. H. Taaning, K. Bjerglund, D. Lupp
and T. Skrydstrup, J. Am. Chem. Soc., 2011, 133, 6061.
11 S. D. Friis, R. H. Taaning, A. T. Lindhardt and T. Skrydstrup, J. Am.
Chem. Soc., 2011, 133, 18114.
12 (a) T. Ueda, H. Konishi and K. Manabe, Org. Lett., 2012, 14, 3100;
(b) T. Ueda, H. Konishi and K. Manabe, Tetrahedron Lett., 2012,
53, 5171; (c) T. Fujihara, T. Hosoki, Y. Katafuchi, T. Iwai, J. Terao
and Y. Tsuji, Chem. Commun., 2012, 48, 8012. For recent application
of phenyl formate in organic synthesis, see: (d) Y. Hoshimoto,
T. Ohata, Y. Sasaoka, M. Ohashi and S. Ogoshi, J. Am. Chem. Soc.,
2014, 136, 15877.
13 T. Ueda, H. Konishi and K. Manabe, Org. Lett., 2012, 14, 5370.
14 (a) T. Ueda, H. Konishi and K. Manabe, Angew. Chem., Int. Ed., 2013,
52, 8611; (b) T. Ueda, H. Konishi and K. Manabe, Org. Lett., 2013,
15, 5370.
15 H. Konishi, T. Ueda and K. Manabe, Org. Synth., 2014, 91, 39.
16 (a) E.-i. Negishi, Y. Zhang, I. Shimoyama and G. Wu, J. Am. Chem.
Soc., 1989, 111, 8018; (b) E.-i. Negishi, H. Makabe, I. Shimoyama,
G. Wu and Y. Zhang, Tetrahedron, 1998, 54, 1095.
17 T. Morimoto, M. Fujioka, K. Fuji, K. Tsutsumi and K. Kakiuchi,
J. Organomet. Chem., 2007, 692, 625.
Scheme 4 Assumed reaction mechanism.
does not require this. Therefore, phenyl formate is not simply a
CO surrogate, but it also generates phenol during the reaction,
which promotes the reaction under mild conditions.23
In conclusion, a variety of cyclic carbonyl compounds could
be accessed via a concise, Pd-catalyzed carbonylation and
cyclization of haloarenes bearing nucleophilic moieties. All
the reactions could be performed using phenyl formate as a
CO surrogate, eliminating the need for external CO gas, demon-
strating high levels of efficiency and practicality. Notably, the
catalytic reaction provided several biologically active compounds,
such as 4H-3,1-benzoxazin-4-one derivatives. This general, user-
friendly carbonylative cyclization protocol for the synthesis of
cyclic carbonyl compounds would be preferable to that using CO
gas, and will accelerate the generation of libraries containing a
wide array of cyclic carbonyl products.
18 J. R. Martinelli, D. A. Watson, D. M. M. Freckmann, T. E. Barder and
S. L. Buchwald, J. Org. Chem., 2008, 73, 7102.
19 O. Lagerlund and M. Larhed, J. Comb. Chem., 2006, 8, 4.
20 For selected examples of biological activities of 4H-3,1-benzoxazin-4-ones,
see: (a) L. Hedstrom, A. R. Moorman, J. Dobbs and R. H. Abeles,
Biochemistry, 1984, 23, 1753; (b) A. Krantz, R. W. Spencer, T. F. Tam,
T. J. Liak, L. J. Copp, E. M. Thomas and S. P. Rafferty, J. Med. Chem., 1990,
33, 464; (c) G. Fenton, C. G. Newton, B. M. Wyman, P. Bagge, D. I. Dron,
D. Riddell and G. D. Jones, J. Med. Chem., 1989, 32, 265.
21 (a) Beller et al. reported a synthesis of 2-amino-4H-3,1-benzoxazin-4-
one using aniline, isocyanate, and Mo(CO)6 as a CO surrogate.
X.-F. Wu, M. Sharif, K. Shoaib, H. Neumann, A. Pews-Davtyan,
P. Langer and M. Beller, Chem. – Eur. J., 2013, 19, 6230; (b) After
submission of the present paper, similar synthetic method has been
reported: W. Li and X.-F. Wu, J. Org. Chem., 2014, 79, 10410.
This work was partly supported by the Uehara Memorial
Foundation and Platform for Drug Discovery, Informatics, and
Structural Life Science from the Ministry of Education, Culture,
Sports, Science and Technology, Japan.
Notes and references
¨
22 H. Koistinen, G. Wohlfahrt, J. M. Mattsson, P. Wu, J. Lahdenpera
1 For selected reviews, see: (a) G. Kiss, Chem. Rev., 2001, 101, 3435;
and U.-H. Stenman, Prostate, 2008, 68, 1143.
(b) A. Brennfu¨hrer, H. Neumann and M. Beller, Angew. Chem., 23 J. R. Martinelli, T. P. Clark, D. A. Watson, R. H. Munday and S. L.
Int. Ed., 2009, 48, 4114.
Buchwald, Angew. Chem., Int. Ed., 2007, 46, 8460.
Chem. Commun.
This journal is ©The Royal Society of Chemistry 2014